The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes
Open accessAbstract
Summary: Bacteria living as biofilm are frequently reported to exhibit inherent tolerance to antimicrobial compounds, and might therefore contribute to the persistence of infections. Antimicrobial peptides are attracting increasing interest as new potential antimicrobial therapeutics; however, little is known about potential mechanisms, which might contribute to resistance or tolerance development towards these compounds in biofilms. Here we provide evidence that a spatially distinct subpopulation of metabolically active cells in Pseudomonas aeruginosa biofilms is able to develop tolerance to the antimicrobial peptide colistin. On the contrary, biofilm cells exhibiting low metabolic activity were killed by colistin. We demonstrate that the subpopulation of metabolically active cells is able to adapt to colistin by inducing a specific adaptation mechanism mediated by the pmr operon, as well as an unspecific adaptation mechanism mediated by the mexAB‐oprM genes. Mutants defective in either pmr ‐mediated lipopolysaccharide modification or in mexAB‐oprM ‐mediated antimicrobial efflux were not able to develop a tolerant subpopulation in biofilms. In contrast to the observed pattern of colistin‐mediated killing in biofilms, conventional antimicrobial compounds such as ciprofloxacin and tetracycline were found to specifically kill the subpopulation of metabolically active biofilm cells, whereas the subpopulation exhibiting low metabolic activity survived the treatment. Consequently, targeting the two physiologically distinct subpopulations by combined antimicrobial treatment with either ciprofloxacin and colistin or tetracycline and colistin almost completely eradicated all biofilm cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“reside in biofilms and are intrinsically tolerant to antimicrobial attack (Costerton et al., 1999; Stewart and Costerton, 2001; Donlan and Costerton, 2002).”
BackgroundAntimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Microbial Biofilms: from Ecology to Molecular Genetics
Davey, M. E., & O'toole, G. A. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.847-867.2000 · Cited by 3,086
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J., & Schweizer, H. P. (1998) · Gene · doi:10.1016/s0378-1119(98)00130-9 · Cited by 1,922
Survival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
Adaptive radiation in a heterogeneous environment
Rainey, P. B., & Travisano, M. (1998) · Nature · doi:10.1038/27900 · Cited by 1,306
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Fruiting body formation by Bacillus subtilis
Branda, S. S., González-Pastor, J. E., Ben-Yehuda, S., Losick, R., & Kolter, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191384198 · Cited by 1,129
A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms
Allesen‐Holm, M., Barken, K. B., Yang, L., Klausen, M., Webb, J. S., Kjelleberg, S., Molin, S., Givskov, M., & Tolker‐Nielsen, T. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05008.x · Cited by 1,086
Self-citationEfflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Andersen, J. B., Sternberg, C., Poulsen, L. K., Bjørn, S. P., Givskov, M., & Molin, S. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.6.2240-2246.1998 · Cited by 1,033
Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants
Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03525.x · Cited by 1,020
Self-citationWalters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Cationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 2×
“AMPs can be produced by humans as part of the innate immune defence system and are increasingly administered as treatment against microbial infections in humans (Hancock, 2001; Zasloff, 2002; Falagas and Kasiakou, 2006; Hancock and Sahl, 2006; Li et al., 2006).”
BackgroundSpoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Hall-Stoodley, L., Hu, F. Z., Gieseke, A., Nistico, L., Nguyen, D., Hayes, J., Forbes, M., Greenberg, D. P., Dice, B., Burrows, A., et al. (2006) · JAMA · doi:10.1001/jama.296.2.202 · Cited by 878
Infections Caused by Pseudomonas aeruginosa
Bodey, G. P., Bolivar, R., Fainstein, V., & Jadeja, L. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.2.279 · Cited by 853
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Infections caused by Pseudomonas aeruginosa.
MUSSER, A. W., & Beamer, P. R. (1961) · PubMed · Cited by 728
Self-generated diversity produces “insurance effects” in biofilm communities
Boles, B. R., Thoendel, M., & Singh, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407460101 · Cited by 670
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Klausen, M., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03677.x · Cited by 556
Self-citationAntimicrobial resistance of Pseudomonas aeruginosa biofilms
Drenkard, E. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.08.009 · Cited by 520
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm
Banin, E., Brady, K. M., & Greenberg, E. P. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.3.2064-2069.2006 · Cited by 473
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Brooun, A., Liu, S., & Lewis, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.640-646.2000 · Cited by 473
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 456
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Current Protocols in Microbiology
(2005) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9780471729259 · Cited by 405
Multiple Roles of Biosurfactants in Structural Biofilm Development by Pseudomonas aeruginosa
Pamp, S. J., & Tolker-Nielsen, T. (2007) · Journal of Bacteriology · doi:10.1128/jb.01515-06 · Cited by 404
Self-citationShafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391
Stratified Growth in Pseudomonas aeruginosa Biofilms
Werner, E., Roe, F., Bugnicourt, A., Franklin, M. J., Heydorn, A., Molin, S., Pitts, B., & Stewart, P. S. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.6188-6196.2004 · Cited by 384
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Bao, Y., Lies, D. P., Fu, H., & Roberts, G. P. (1991) · Gene · doi:10.1016/0378-1119(91)90604-a · Cited by 336
Trent, M. S., Ribeiro, A. A., Lin, S., Cotter, R. J., & Raetz, C. R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106961200 · Cited by 336
Jensen, T., Pedersen, S. S., Garne, S., Heilmann, C., Høiby, N., & Koch, C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.831 · Cited by 314
Kessler, B., de Lorenzo, V., & Timmis, K. N. (1992) · Molecular and General Genetics MGG · doi:10.1007/bf00587591 · Cited by 312
Distribution of Bacterial Growth Activity in Flow-Chamber Biofilms
Sternberg, C., Christensen, B. B., Johansen, T., Toftgaard Nielsen, A., Andersen, J. B., Givskov, M., & Molin, S. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.9.4108-4117.1999 · Cited by 311
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Mini‐Tn 7 transposons for site‐specific tagging of bacteria with fluorescent proteins
Lambertsen, L., Sternberg, C., & Molin, S. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00605.x · Cited by 303
An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants
Choi, K.-H., & Schweizer, H. P. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-30 · Cited by 300
De Kievit, T. R., Parkins, M. D., Gillis, R. J., Srikumar, R., Ceri, H., Poole, K., Iglewski, B. H., & Storey, D. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1761-1770.2001 · Cited by 294
Schweizer, H. P. (2003) · PubMed · Cited by 287
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Koch, B., Jensen, L. E., & Nybroe, O. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00246-9 · Cited by 272
Eradication of early Pseudomonas aeruginosa infection
Høiby, N., Frederiksen, B., & Pressler, T. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.05.018 · Cited by 255
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis
Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 249
‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer
Ainsworth, G. C., Brown, A. M., & Brownlee, G. G. (1947) · Nature · doi:10.1038/160263a0 · Cited by 239
Genome Organization in Pseudomonas
Holloway, B. W., & Morgan, A. F. (1986) · Annual Review of Microbiology · doi:10.1146/annurev.mi.40.100186.000455 · Cited by 239
Lipid A Modifications in Polymyxin-resistant Salmonella typhimurium
Zhou, Z., Ribeiro, A. A., Lin, S., Cotter, R. J., Miller, S. I., & Raetz, C. R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106960200 · Cited by 230
McPhee, J. B., Bains, M., Winsor, G., Lewenza, S., Kwasnicka, A., Brazas, M. D., Brinkman, F. S. L., & Hancock, R. E. W. (2006) · Journal of Bacteriology · doi:10.1128/jb.00053-06 · Cited by 225
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
NEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSIS
Littlewood, J. M., Miller, M. G., Ghoneim, A. T., & Ramsden, C. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92222-6 · Cited by 203
Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Srikumar, R., Kon, T., Gotoh, N., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.65 · Cited by 184
Haagensen, J. A. J., Klausen, M., Ernst, R. K., Miller, S. I., Folkesson, A., Tolker-Nielsen, T., & Molin, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.00720-06 · Cited by 182
Self-citationHelander, I. M., Kilpeläinen, I., & Vaara, M. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00329.x · Cited by 170
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Aas, F. E., Wolfgang, M. C., Frye, S. A., Dunham, S. A., Løvold, C., & Koomey, M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03193.x · Cited by 165
Lee, B., Haagensen, J. A. J., Ciofu, O., Andersen, J. B., Høiby, N., & Molin, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5247-5255.2005 · Cited by 165
Loss of social behaviors by Myxococcus xanthus during evolution in an unstructured habitat
Velicer, G. J., Kroos, L., & Lenski, R. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12376 · Cited by 163
Antibacterial peptides and proteins with multiple cellular targets
Otvos, L. J. (2005) · Journal of Peptide Science · doi:10.1002/psc.698 · Cited by 162
Klausen, M., Gjermansen, M., Kreft, J., & Tolker‐Nielsen, T. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00280.x · Cited by 148
Self-citationKwon, D. H., & Lu, C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1615-1622.2006 · Cited by 135
Growing and Analyzing Biofilms in Flow Cells
Sternberg, C., & Tolker‐Nielsen, T. (2006) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01b02s00 · Cited by 128
Self-citationSchweizer, H. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.394 · Cited by 123
Imamura, Y., Higashiyama, Y., Tomono, K., Izumikawa, K., Yanagihara, K., Ohno, H., Miyazaki, Y., Hirakata, Y., Mizuta, Y., Kadota, J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1377-1380.2005 · Cited by 92
Johansen, H. K., Nørregaard, L. L., Gøtzsche, P. C., et al. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.10457 · Cited by 87
Self-citationA ten year review of Colomycin
Littlewood, J. M., Koch, C., Lambert, P. A., Høiby, N., Elborn, J. S., Conway, S. P., Dinwiddie, R., & Duncan-Skingle, F. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0834 · Cited by 72
Suzuki, T., Hayashi, K., Fujikawa, K., & Tsukamoto, K. (1965) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a128082 · Cited by 52
Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae
Bogdanovich, T., Bozdoğan, B., & Appelbaum, P. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.893-898.2006 · Cited by 43
Cited by
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
The biofilm life cycle: expanding the conceptual model of biofilm formation
Sauer, K., Stoodley, P., Goeres, D. M., Hall-Stoodley, L., Burmølle, M., Stewart, P. S., & Bjarnsholt, T. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00767-0 · Cited by 1,404
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Metadata
- Authors
- Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2008-02-28
- Volume
- 68
- Issue
- 1
- Pages
- 223-240
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W2149483355
- Cited by
- 486
- References
- 92
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.